Vertex Pharmaceuticals Incorporated (VRTX)
Nasdaq: VRTX · Pharmaceutical Preparations · Boston, MA · filing with the SEC since 1995
Grade7.0
◀ Past 7.3● Present 7.6▶ Future 5.9
Who runs Vertex Pharmaceuticals Incorporated
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Kewalramani Reshma
CEO & President. First filing Apr 2018, latest Nov 10, 2026, 31 filings in all.
Officers reporting now
14
of 24 people with a filing in the last fifteen months
Directors reporting now
10
37 people on the record since 2006
Officerssales are open-market, Nov 10, 2025 to Nov 10, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kewalramani Reshma | CEO & President | Apr 2018 | Nov 10, 2026 | 14 · $26.0M |
| Van Grunsven Jasper | EVP, CP and NPPO | Sep 2026 | Sep 10, 2026 | none |
| Ambrose Kristen | SVP & Chief Accounting Officer | May 2021 | Sep 1, 2026 | 5 · $2.0M |
| Sachdev Amit | EVP Chief Patient & Ext Af Off | Jul 2007 | Jul 23, 2026 | 9 · $28.4M |
| Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Oct 2019 | Jul 23, 2026 | 8 · $6.5M |
| Mckechnie Duncan | EVP, Chief Commercial Officer | Jul 2025 | Jul 7, 2026 | 5 · $5.7M |
| Liu Joy | EVP and Chief Legal Officer | Mar 2021 | Jul 6, 2026 | 5 · $2.1M |
| Bozic Carmen | EVP and CMO | Oct 2019 | Jun 30, 2026 | 10 · $11.3M |
| Bunnage Mark E. | EVP, Chief Scientific Officer | Feb 2026 | May 19, 2026 | 5 · $3.0M |
| Leiden Jeffrey M | Executive Chairman | Jul 2009 | Feb 26, 2026 | 17 · $60.9M |
| Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sep 2023 | Feb 26, 2026 | 5 · $3.6M |
| Biller Jonathan | EVP and Chief Legal Officer | Sep 2022 | Feb 26, 2026 | 6 · $3.8M |
| Wagner Charles F Jr | EVP, CO & FO | Apr 2019 | Feb 26, 2026 | 3 · $10.8M |
| Altshuler David | EVP, Chief Scientific Officer | May 2012 | Jan 26, 2026 | none |
Directorssales are open-market, Nov 10, 2025 to Nov 10, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Brennan Daniel J. | director | Oct 2026 | Oct 22, 2026 | none |
| Garber Alan M | director | Jun 2017 | Oct 19, 2026 | none |
| Sachs Bruce I | director | Jun 2006 | Oct 19, 2026 | none |
| Bhatia Sangeeta N. | director | Jun 2015 | May 5, 2026 | 2 · $300,000 |
| Carney Lloyd | director | Feb 2019 | May 5, 2026 | none |
| Lagarde Michel | director | Oct 2023 | May 5, 2026 | none |
| Mckenzie Diana | director | Jun 2020 | May 5, 2026 | none |
| Schneider Jennifer | director | May 2024 | May 5, 2026 | none |
| Thornberry Nancy | director | Dec 2023 | May 5, 2026 | none |
| Upadhyay Suketu | director | May 2022 | May 5, 2026 | none |
Earlier names on the record13, newest filing first
Arbuckle Stuart A · officer · last filing Jul 2025Kearney Terrence C · director · last filing May 2024Sanna Bastiano · officer · last filing May 2023Lee Yuchun · director · last filing May 2023Mcglynn Margaret G · director · last filing May 2023Silva Paul M · officer · last filing Mar 2021Parini Michael · officer · last filing Feb 2021Young William D · director · last filing Jun 2020Ullian Elaine · director · last filing Jun 2019Graney Thomas · officer · last filing Oct 2018Smith Ian F · officer · last filing Jul 2018Chodakewitz Jeffrey · officer · last filing Apr 2018Boger Joshua S · officer · last filing Jun 2017
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.